• # LGM Pharma is a Stavudine CAS# 3056-17-5 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Stavudine
  • CAS #: 3056-17-5
  • Mode of Action:

    Stavudine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA.

  • Pharmacodynamics:

    Stavudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Stavudine is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.

  • Metabolism:

    Phosphorylated intracellularly to stavudine triphosphate, the active substrate for HIV-reverse transcriptase.

  • Toxicity:

    Side effects include peripheral neuropathy tingling, burning, numbness, or pain in the hands or feet), fatal lactic acidosis has been reported in patients treated with stavudine (ZERIT) in combination with other antiretroviral agents, severe liver enlargement, inflammation (pain and swelling) of the liver, and liver failure.

  • IUPAC: 1-[(2R, 5S)-5-(hydroxymethyl)-2, 5-dihydrofuran-2-yl]-5-methyl-1, 2, 3, 4-tetrahydropyrimidine-2, 4-dione
  • ATC: J05AF04
  • PubChem: 18283
  • DrugBank: DB00649 (APRD00440)
  • Formula: C11H28Al8O51S8
  • Molecular Mass: 224.2133
  • Synonyms: 2',3'-Didehydro-3'-deoxythimidine 3'-Deoxy-2'-thymidinene Estavudina [INN-Spanish] Sanilvudine Stavudine [Usan:Ban:Inn] Stavudinum [INN-Latin] STV
  • SMILES: CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O
  • AHFS Code: 08:18.08.20
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. We’re working to update our website to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service